4//SEC Filing
Trieu Vuong 4
Accession 0001493152-25-024236
CIK 0000908259other
Filed
Nov 18, 7:00 PM ET
Accepted
Nov 19, 3:45 PM ET
Size
5.8 KB
Accession
0001493152-25-024236
Insider Transaction Report
Form 4
Trieu Vuong
DirectorCHAIRMAN AND CEO10% Owner
Transactions
- Award
Series A Convertible Preferred Stock
2025-11-17+4,065→ 4,065 total→ Com-mon Stock (4,065,000 underlying)
Footnotes (2)
- [F1]Series A Convertible Preferred Stock is convertible at any time at the option of the holder into Common Stock on a one-for-one thousand basis.
- [F2]The shares of Series A Convertible Preferred Stock were issued to Dr. Trieu as compensation pursuant to the accomplishment of performance milestones under a Restricted Stock Agreement dated November 17, 2025.
Documents
Issuer
Oncotelic Therapeutics, Inc.
CIK 0000908259
Entity typeother
Related Parties
1- filerCIK 0001587074
Filing Metadata
- Form type
- 4
- Filed
- Nov 18, 7:00 PM ET
- Accepted
- Nov 19, 3:45 PM ET
- Size
- 5.8 KB